Position Paper on Use of Convalescent Plasma, Serum or Immune Globulin Concentrates as an Element in Response to an Emerging Virus

WHO Team
Blood and other Products of Human Origin (BTT), Medicines and Health Products, Policies and Standards (HPS)
Number of pages
7